Struggling to find Edarbi at your pharmacy? Learn why this blood pressure medication is hard to find in 2026 and what you can do to get your prescription filled.
If you've been prescribed Edarbi (Azilsartan Medoxomil) for high blood pressure and your pharmacist tells you it's out of stock, you're not alone. Many patients across the country are running into the same frustrating problem. You call pharmacy after pharmacy, and the answer is the same — they either don't carry it or can't get it in stock.
In this article, we'll break down exactly why Edarbi can be so hard to find in 2026, what's behind the supply issues, and — most importantly — what you can do about it.
Edarbi is a brand-name prescription medication used to treat high blood pressure (hypertension) in adults. It belongs to a class of drugs called angiotensin II receptor blockers (ARBs). ARBs work by blocking a chemical in your body called angiotensin II, which normally causes blood vessels to tighten. By blocking this chemical, Edarbi helps your blood vessels relax and your blood pressure come down.
Edarbi was originally developed by Takeda Pharmaceuticals and approved by the FDA in 2011. It's now manufactured and marketed by Azurity Pharmaceuticals. It comes in two strengths — 40 mg and 80 mg tablets — and is taken once a day, with or without food.
For a deeper look at how this medication works in your body, check out our guide on how Edarbi works.
One of the biggest reasons Edarbi is hard to find is that there is no generic version of Azilsartan Medoxomil currently available on the market. While the FDA approved an abbreviated new drug application (ANDA) for a generic version in 2022, patent protections have kept generic manufacturers from actually selling it.
Without a generic option, pharmacies rely entirely on the brand-name supply from Azurity Pharmaceuticals. When there's only one manufacturer, any production delay, distribution hiccup, or demand spike can create availability gaps.
Most pharmacies — especially large chains like CVS, Walgreens, and Rite Aid — make stocking decisions based on demand and cost. Since most patients with high blood pressure are prescribed generic ARBs like Losartan, Valsartan, or Olmesartan (which cost a fraction of the price), pharmacies may not keep Edarbi on their shelves at all.
This doesn't mean Edarbi is unavailable. It often means the pharmacy hasn't ordered it because they don't fill enough prescriptions for it to justify carrying it in stock. Your pharmacist may need to place a special order.
Many insurance plans require patients to try cheaper, generic ARBs before they'll approve coverage for Edarbi. This is called step therapy. Because fewer patients end up filling Edarbi prescriptions (after being steered toward generics), pharmacy demand for Edarbi stays low — which circles back to pharmacies not stocking it.
Even when your doctor specifically prescribes Edarbi, your insurance might require prior authorization, which can delay your ability to fill the prescription and add another hurdle to finding it.
The pharmaceutical supply chain has faced widespread disruptions in recent years. While Edarbi is not currently listed on the FDA's official drug shortage list, that doesn't mean it's easy to find everywhere. Regional distribution patterns, wholesaler inventory decisions, and pharmacy ordering cycles all affect whether a particular location has Edarbi on hand at any given time.
For more context on the current availability picture, read our Edarbi shortage update for 2026.
Instead of calling pharmacy after pharmacy, use Medfinder to search for pharmacies near you that have Edarbi in stock. It saves time and helps you find what you need faster.
If your pharmacy doesn't have Edarbi in stock, ask the pharmacist if they can place a special order with their wholesaler. In many cases, the medication can arrive within 1 to 2 business days.
Independent and specialty pharmacies are often more flexible about ordering brand-name medications that large chains don't routinely stock. They may also be more willing to work with your doctor to find solutions. For more tips, see our guide on how to find Edarbi in stock near you.
If Edarbi remains difficult to find, your doctor may be able to switch you to another ARB that's more widely available. Options like Losartan (Cozaar), Valsartan (Diovan), Olmesartan (Benicar), and Telmisartan (Micardis) are all available as affordable generics and work through a similar mechanism. Learn more in our article on alternatives to Edarbi.
Cost can also be a barrier. Edarbi's cash price ranges from $294 to $376 per month without insurance. The manufacturer offers a copay savings card through the Azurity Solutions E-Z Rx Program that can reduce your out-of-pocket cost to as little as $15 per month if you have commercial insurance. For more options, check out our guide on how to save money on Edarbi.
Edarbi is an effective blood pressure medication, but finding it in 2026 can be a challenge. The combination of no generic alternative, low pharmacy stocking, insurance hurdles, and supply chain factors all contribute to the problem. The good news is that with the right tools — like Medfinder — and a proactive approach, you can track it down or work with your doctor to find an alternative that works for you.
Don't let a stocking issue keep you from managing your blood pressure. Your health is too important to put on hold.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
